CLINICAL_TRIALS
trial_result
· 2024-10-23
Clinical Trial Update: Study for Participants With Ulcerative Colitis Previously Enrolled in Etrolizumab Phase II/III Studies [Phase 3]
Summary
A Phase III study of etrolizumab in ulcerative colitis has been terminated; results were posted after termination.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Hoffmann-La Roche | Conditions: Ulcerative Colitis | Phase 3 | Status: TERMINATED | Results posted: 2024-10-23